Howe & Rusling Inc. Reduces Stock Position in Corteva, Inc. (NYSE:CTVA)

Howe & Rusling Inc. decreased its position in shares of Corteva, Inc. (NYSE:CTVA) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,416 shares of the company’s stock after selling 629 shares during the quarter. Howe & Rusling Inc.’s holdings in Corteva were worth $2,245,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CTVA. Flagship Wealth Advisors LLC purchased a new stake in shares of Corteva in the fourth quarter valued at about $25,000. Noble Wealth Management PBC acquired a new position in shares of Corteva during the 4th quarter worth approximately $26,000. Hager Investment Management Services LLC purchased a new stake in Corteva in the 4th quarter valued at approximately $27,000. Golden State Wealth Management LLC purchased a new stake in Corteva during the 4th quarter worth about $32,000. Finally, Centricity Wealth Management LLC acquired a new position in Corteva in the 4th quarter valued at about $34,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 1.4 %

Shares of Corteva stock opened at $62.73 on Thursday. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24. The stock has a market cap of $43.01 billion, a price-to-earnings ratio of 48.63, a price-to-earnings-growth ratio of 1.68 and a beta of 0.79. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The company has a fifty day moving average price of $62.54 and a 200 day moving average price of $60.01.

Corteva (NYSE:CTVA) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.08%. Corteva’s dividend payout ratio is currently 52.71%.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 26,560 shares of the business’s stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.14% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Barclays boosted their price objective on shares of Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 21st. Wells Fargo & Company increased their price target on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. BNP Paribas raised Corteva to a “hold” rating in a research report on Monday, February 10th. UBS Group reduced their target price on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Finally, KeyCorp lifted their price target on Corteva from $68.00 to $70.00 and gave the company an “overweight” rating in a report on Friday, February 7th. One analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $68.00.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.